Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile Associated Diarrhea (CDAD)”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Testing effectiveness (Phase 2)Study completedNCT00382304
What this trial is testing

The Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea

Who this might be right for
Pseudomembranous ColitisClostridium Difficile DiarrheaAntibiotic-Associated Diarrhea
Genzyme, a Sanofi Company 24
Post-approval studies (Phase 4)Ended earlyNCT00177970
What this trial is testing

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
University of Pittsburgh 14
Large-scale testing (Phase 3)Study completedNCT01983683
What this trial is testing

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

Who this might be right for
Clostridium Difficile Infection
Actelion 631
Large-scale testing (Phase 3)Study completedNCT00314951
What this trial is testing

Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 629
Not applicableStudy completedNCT01401023
What this trial is testing

Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)

Who this might be right for
DiarrheaClostridium Difficile
Gary E. Stein, Pharm.D. 10
Testing effectiveness (Phase 2)Study completedNCT01559545
What this trial is testing

A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis

Who this might be right for
Clostridium Difficile Associated Diarrhea
Dr. Reddy's Laboratories Limited 60
Large-scale testing (Phase 3)Study completedNCT01987895
What this trial is testing

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea

Who this might be right for
Clostridium Difficile Infection
Actelion 632
Not applicableLooking for participantsNCT06839209
What this trial is testing

Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea

Who this might be right for
Clostridium; Difficile, As Cause of Disease Classified ElsewhereClostridium Difficile Diarrhea
ABResearch S.r.l. 18
Large-scale testing (Phase 3)Study completedNCT02218372
What this trial is testing

Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
Astellas Pharma Europe B.V. 148
Early research (Phase 1)Study completedNCT02835118
What this trial is testing

Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)

Who this might be right for
Clostridium Difficile Associated Diarrhea (CDAD)
Merck Sharp & Dohme LLC 30
Testing effectiveness (Phase 2)Study completedNCT00097422
What this trial is testing

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Diarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Testing effectiveness (Phase 2)Study completedNCT01232595
What this trial is testing

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

Who this might be right for
Moderate Clostridium Difficile Infection
Novartis Pharmaceuticals 109
Not applicableUnknownNCT02681068
What this trial is testing

MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation

Who this might be right for
Clostridium Infections
University of Cologne 1,000
Post-approval studies (Phase 4)WithdrawnNCT00304863
What this trial is testing

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Who this might be right for
EnterocolitisPseudomembranous ColitisAntibiotic-associated Colitis
Michael E. DeBakey VA Medical Center
Large-scale testing (Phase 3)Study completedNCT01598311
What this trial is testing

CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006)

Who this might be right for
Clostridium Difficile Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 608
Large-scale testing (Phase 3)Study completedNCT02179658
What this trial is testing

Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile
Astellas Pharma Inc 210
Large-scale testing (Phase 3)Study completedNCT01597505
What this trial is testing

Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)

Who this might be right for
Clostridium Difficile Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 606
Large-scale testing (Phase 3)Ended earlyNCT00466635
What this trial is testing

Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

Who this might be right for
Enterocolitis, PseudomembranousDiarrheaClostridium Difficile
Genzyme, a Sanofi Company 65
Large-scale testing (Phase 3)Ended earlyNCT03105479
What this trial is testing

Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile Infection
Actelion 1
Testing effectiveness (Phase 2)Study completedNCT01925417
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Who this might be right for
Recurrent Clostridium Difficile Infection
Rebiotix Inc. 34
Next Page